Interim Analysis of New Study Suggests Boosted INVIRASE May Achieve Similar Levels of HIV Suppression to Boosted Lopinavir with a Favorable Lipid Profile
13th Nov 2006, 16:41 GMT
Encouraging results from an interim analysis of a new study suggest that the boosted protease inhibitor INVIRASE 500 mg/r has the potential to achieve comparable levels of viral suppression to the most commonly used PI, lopinavir/r (Kaletra ), with less lipid elevation.
Interim Analysis of New Study Suggests Boosted INVIRASE May Achieve Similar Levels of HIV Suppression to Boosted Lopinavir with a Favorable Lipid Profile related news:
- Interim Analysis Of New Study Suggests Boosted INVIRASE(R) May Achieve Similar Levels Of HIV Suppression To Boosted Lopinavir — Health News from Medical News Today
- New study indicates Invirase results in similar levels of viral suppression to lopinavir — EurekAlert! - Breaking News
- New Study Indicates Boosted Invirase 500 Patients Achieve Similar Levels of Viral Suppression to Boosted Lopinavir but with a Better Lipid Profile — Presseportal.de Wirtschaft
- Volume 194, number 12: Treatment Benefit on Cerebrospinal Fluid HIV-1 Levels in the Setting of Systemic Virological Suppression and Failure — J Infect Dis Latest Issue
- Tipranavir May Be Helpful for Multidrug-Resistant HIV-1 Infection — Medscape Hiv-Aids Headlines
- Treat HIV-Positive Addicts To Slow AIDS In Russia, Stanford Study Says — Health News from Medical News Today
- Volume 194, number 12: A Randomized, Partially Blinded Phase 2 Trial of Antiretroviral Therapy, HIV-Specific Immunizations, and Interleukin-2 Cycles to Promote Efficient Control of Viral Replication (ACTG A5024) — J Infect Dis Latest Issue
- Study suggests red meat may raise risk of breast cancer — WOODTV - Health
- Profile: The Iraq Study Group — BBC News | Latest Published Stories | UK Edition
- Favrille Announces Interim Analysis of Secondary Endpoint from Pivotal Phase 3 Clinical Trial of FavId Following Rituxan in Follicular B-Cell Non-Hodgkin's Lymphoma — Bio-Technology News from StratCenter.com
Latest news from Pharmaceuticals News from StratCenter.com:
- Spectrum Pharmaceuticals to Receive $5 mln Milestone Payment From PAR Pharmaceutical for Sumatriptan Injection
- Medco to Present at the Credit Suisse Annual Healthcare Conference
- Bob Dole Medicare Podcast Helps Seniors through 2007 Drug Coverage Enrollment Process
- Unique Sugar Improves Energy, Pain and Quality of Life in Fibromyalgia and Chronic Fatigue Patients!
- Care Clinic Purchases Pinnacle Easy Care
- Pegasystems Enhances 2 Business Critical BPM Frameworks for the Healthcare Industry
- Isis Cholesterol Drug Shown Effective
- Taro Receives Marketing Authorization in UK for Etopan XL Tablets 600 mg, Etodolac
- Nymox Reports Q3 2006 Financial Results
- RemoteMDx Raises $6 mln in Private Placement